World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
155
Citations
84800
World Ranking
973
National Ranking
558

Jorge S. Reis-Filho publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Jorge S. Reis-Filho sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 683 publications — 80th percentile

80% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Jorge S. Reis-Filho D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Jorge S. Reis-Filho sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 155 D-Index — 95th percentile

95% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Jorge S. Reis-Filho is affiliated with the Memorial Sloan Kettering Cancer Center in the United States. Their research spans significant contributions in medicine, particularly within cancer-related fields, combining expertise in biochemistry, genetics, and molecular biology.

Their primary research fields include:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

Subfields of study involve cancer-focused areas and diagnostic disciplines such as:

  • Cancer Research
  • Oncology
  • Molecular Biology
  • Pulmonary and Respiratory Medicine
  • Pathology and Forensic Medicine

The main topics covered in their work reflect a focus on cancer genomics, diagnostics, and treatment strategies including:

  • Cancer Genomics and Diagnostics
  • Lung Cancer Treatments and Mutations
  • Genetic factors in colorectal cancer
  • Breast Cancer Treatment Studies
  • Advanced Breast Cancer Therapies
  • HER2/EGFR in Cancer Research
  • Radiomics and Machine Learning in Medical Imaging

Jorge S. Reis-Filho has contributed extensively to the scientific literature, with frequent publications in notable venues such as:

  • Cancer Research
  • Journal of Clinical Oncology
  • Annals of Oncology
  • npj Breast Cancer
  • Modern Pathology

Frequent collaborators include:

  • Britta Weigelt
  • Pier Selenica
  • Fresia Pareja
  • Pedram Razavi
  • Sarat Chandarlapaty

Among their recent publications are:

  • Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients, 2022, Cell
  • Pathogenesis of Triple-Negative Breast Cancer, 2022, Annual Review of Pathology Mechanisms of Disease
  • ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group, 2022, Annals of Oncology
  • Delivering precision oncology to patients with cancer, 2022, Nature Medicine
  • Multimodal data integration using machine learning improves risk stratification of high-grade serous ovarian cancer, 2022, Nature Cancer

Best Publications

  • Triple-negative breast cancer.

    William D. Foulkes;Ian E. Smith;Jorge S. Reis-Filho

  • The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014

    R. Salgado;C. Denkert;S. Demaria;N. Sirtaine

  • Pan-cancer analysis of whole genomes

    Peter J. Campbell;Gad Getz;Jan O. Korbel;Joshua M. Stuart

  • International network of cancer genome projects

    Thomas J. Hudson;Thomas J. Hudson;Warwick Anderson;Axel Aretz;Anna D. Barker

  • The landscape of cancer genes and mutational processes in breast cancer

    Philip J. Stephens;Patrick S. Tarpey;Helen Davies;Peter Van Loo;Peter Van Loo

  • Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAF

    Sonja J. Heidorn;Carla Milagre;Steven Whittaker;Arnaud Nourry

  • Basal-Like Breast Cancer: A Critical Review

    Emad A. Rakha;Jorge S. Reis-Filho;Ian O. Ellis

  • Triple negative tumours : a critical review

    J S Reis-Filho;Andrew Tutt;Andrew Tutt

  • RAS mutations in cutaneous squamous-cell carcinomas in patients treated with BRAF inhibitors.

    Fei Su;Amaya Viros;Carla Milagre;Kerstin Trunzer

  • Mutation Tracking in Circulating Tumor DNA Predicts Relapse in Early Breast Cancer

    Isaac Garcia-Murillas;Gaia Schiavon;Gaia Schiavon;Britta Weigelt;Charlotte Ng

  • Breast cancer prognostic classification in the molecular era: the role of histological grade

    Emad A. Rakha;Jorge S. Reis-Filho;Frederick Baehner;David J. Dabbs

  • Resistance to therapy caused by intragenic deletion in BRCA2

    Stacey L. Edwards;Rachel Brough;Christopher J. Lord;Rachael Natrajan

  • Complex landscapes of somatic rearrangement in human breast cancer genomes.

    Philip J. Stephens;David J. Mcbride;Meng-lay Lin;Ignacio Varela

  • Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data

    François-Clément Bidard;François-Clément Bidard;Dieter Peeters;Tanja Fehm;Franco Nolé

  • BRCA1 Basal-like Breast Cancers Originate from Luminal Epithelial Progenitors and Not from Basal Stem Cells

    Gemma Molyneux;Felipe C. Geyer;Fiona-Ann Magnay;Afshan McCarthy

  • Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group.

    F. Mosele;J. Remon;J. Mateo;C. B. Westphalen

  • Gene expression profiling in breast cancer: classification, prognostication, and prediction

    Jorge S Reis-Filho;Lajos Pusztai

  • Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists

    Sunil Badve;David J. Dabbs;Stuart J. Schnitt;Frederick L. Baehner

  • The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers.

    Pedram Razavi;Matthew T. Chang;Guotai Xu;Chaitanya Bandlamudi

  • FGFR1 Amplification Drives Endocrine Therapy Resistance and Is a Therapeutic Target in Breast Cancer

    Nicholas Turner;Alex Pearson;Rachel Sharpe;Maryou Lambros

Frequent Co-Authors

Charlotte K.Y. Ng
Charlotte K.Y. Ng Humanitas University
Rachael Natrajan
Rachael Natrajan Institute of Cancer Research
Alan Ashworth
Alan Ashworth University of California, San Francisco
Salvatore Piscuoglio
Salvatore Piscuoglio Humanitas University
Alan Mackay
Alan Mackay Institute of Cancer Research
Sunil R. Lakhani
Sunil R. Lakhani University of Queensland
Ian O. Ellis
Ian O. Ellis University of Nottingham
Edi Brogi
Edi Brogi Memorial Sloan Kettering Cancer Center
Christopher J. Lord
Christopher J. Lord Institute of Cancer Research
Larry Norton
Larry Norton Memorial Sloan Kettering Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those considering a future in medicine but interested in flexible learning, online healthcare programs provide an accessible route into the field. Options range from entry-level to advanced degrees and touch on numerous career opportunities within healthcare.

A popular starting point is earning the cheapest online healthcare administration degree. This degree is ideal for students who wish to move into healthcare management or administrative roles without the commitment of medical school. For those seeking leadership or specialized positions, a master's in healthcare administration online builds on foundational knowledge and opens doors to advanced supervisory roles.

Alternatively, nurses who wish to expand their impact might explore the cheapest online bsn to dnp programs, leading to a Doctor of Nursing Practice. For those interested in pharmaceuticals, online pharmacy school programs allow aspiring pharmacists to pursue their doctorate with flexibility.

Exploring these related online degrees can be a practical and affordable way to launch or advance a healthcare career, whether you are entering the field or seeking to specialize further.

Best Scientists Citing Jorge S. Reis-Filho

Trending Scientists

Recently Published Articles